High-Risk Heart Health Lipid and Lp(a) Panel
This blood test panel combines advanced lipids, ApoB, and Lp(a) with key metabolic markers to clarify cardiovascular risk and guide next steps.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, meaning you get multiple cardiovascular-related measurements from one blood draw. It is designed for situations where a basic cholesterol panel does not feel like enough—especially if you have a strong family history, you are already on lipid-lowering medication, or you have been surprised by an elevated lipoprotein(a) (Lp(a)) result and want a clearer plan.
Do I need this panel?
You may want this panel if you are trying to reduce cardiovascular risk and your questions go beyond “Is my LDL normal?” Common reasons include a family history of early heart attack or stroke, known coronary artery disease, diabetes or metabolic syndrome, chronic kidney disease, or persistently abnormal lipids despite lifestyle changes.
This panel is also useful if you are already taking a statin, ezetimibe, bempedoic acid, or a PCSK9-targeting therapy and you want to confirm that the therapy is lowering the particles that matter most (often reflected by ApoB and/or LDL particle measures), not just the cholesterol number.
If you have ever been told your Lp(a) is high—or you have a close relative with high Lp(a)—this panel helps you interpret that inherited risk alongside your overall atherogenic burden (the amount of cholesterol-carrying particles in circulation) and your triglyceride/HDL pattern.
Your results can support clinician-directed care and shared decision-making, but they are not a diagnosis by themselves. Use the full pattern across the panel—plus your blood pressure, symptoms, imaging, and medication history—to decide what to do next.
This panel combines standard and advanced lipid measurements; some values may be directly measured while others are calculated or method-dependent, so trending on the same platform is helpful.
Lab testing
Order the High-Risk Heart Health Lipid and Lp(a) Panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault lets you order this high-risk heart health lab panel so you can see advanced lipid risk markers in one place, without piecing together separate tests. You get a single set of results that makes it easier to connect the dots between ApoB, Lp(a), triglycerides, HDL, and particle-related measures.
After your results are in, you can use PocketMD to ask practical questions like how to prioritize next steps, what patterns suggest insulin resistance versus inherited risk, and which markers are most useful to repeat after a medication or lifestyle change.
This panel is a good “deep dive” option when you want a more complete risk picture. If you are making changes between deep dives, you can also choose a simpler interval check (such as a basic lipid-focused option) to track direction without over-testing.
- One blood draw with multiple cardiovascular risk markers
- Designed for people with family history or on lipid-lowering therapy
- PocketMD support to interpret patterns across results
- Useful for trending over time after treatment changes
Key benefits of the High-Risk Heart Health Lipid and Lp(a) Panel
- Clarifies risk when a standard cholesterol panel feels incomplete, especially with family history or early events.
- Separates inherited Lp(a)-driven risk from lifestyle-driven patterns like high triglycerides and low HDL.
- Uses ApoB and particle-related measures to estimate atherogenic particle burden, not just cholesterol content.
- Helps you evaluate whether lipid-lowering therapy is achieving the intended target pattern (and supports retesting after changes).
- Identifies discordance (for example, “normal LDL-C” but high ApoB/LDL-P) that can change the conversation about intensity of treatment.
- Provides context for triglyceride-rich lipoproteins and remnant risk using non-HDL and related markers.
- Creates a single, organized set of results you can review with PocketMD to decide what to focus on next.
What is the High-Risk Heart Health Lipid and Lp(a) panel?
The High-Risk Heart Health Lipid and Lp(a) panel is a bundled set of blood tests that looks at cardiovascular risk through multiple lenses at once. Instead of relying on one number (like LDL cholesterol), it combines standard lipids with advanced markers that better reflect the number and type of cholesterol-carrying particles in your blood.
A key component is lipoprotein(a), written as Lp(a). Lp(a) is a genetically influenced lipoprotein that can raise atherosclerotic cardiovascular disease risk even when your other lipids look “fine.” Because it is largely inherited, Lp(a) is often the missing explanation when heart disease runs in your family.
The panel also emphasizes ApoB (apolipoprotein B), which is a structural protein found on most atherogenic particles (including LDL and several triglyceride-rich particles). In many people—especially those with insulin resistance—ApoB can be a more direct way to estimate particle burden than LDL-C alone.
By combining these markers with triglycerides, HDL, and related calculations, the panel helps you interpret whether your risk pattern is driven more by inherited factors (like Lp(a)), metabolic factors (like high triglycerides and low HDL), or a high overall burden of ApoB-containing particles. That pattern is what guides the most useful next step: lifestyle focus, medication adjustment, additional testing, or a repeat interval.
What do my panel results mean?
Lower-risk patterns across the panel
A lower-risk pattern usually looks like low ApoB (or low LDL particle burden), favorable triglycerides, and a healthy HDL/triglyceride relationship, with non-HDL cholesterol tracking appropriately with LDL-C. If Lp(a) is low as well, your inherited lipoprotein-driven risk is less likely to be a major driver. Even with a favorable pattern, your overall risk still depends on age, blood pressure, smoking status, diabetes, kidney function, and any known plaque—so the panel is best used as one part of your risk picture.
Optimal patterns (what you are aiming for)
An optimal panel pattern is one where the atherogenic particle signal is consistently controlled: ApoB and related particle measures align with LDL-C and non-HDL, triglycerides are not elevated, and HDL is not suppressed by a high-triglyceride pattern. If you are on therapy, “optimal” often means your key targets improved in the direction you and your clinician intended, and the changes are consistent across markers (for example, ApoB falls along with LDL-C and non-HDL). If Lp(a) is elevated, “optimal” may still include a higher Lp(a) number—because it is often stable—but with tighter control of the modifiable markers around it.
Higher-risk patterns (what deserves follow-up)
Higher-risk patterns include any combination of elevated Lp(a), elevated ApoB (or LDL particle burden), high non-HDL cholesterol, high triglycerides, or a mismatch where LDL-C looks acceptable but ApoB/particle measures remain high. This can happen in insulin resistance, type 2 diabetes, and some genetic lipid disorders. A high Lp(a) result is often “sticky” over time and may shift the strategy toward more aggressive control of ApoB-containing particles and closer monitoring, especially if you also have family history or known plaque. If triglycerides are high, the follow-up may focus on metabolic drivers (weight, alcohol, refined carbohydrates, thyroid status, diabetes control) and medication choices that address triglyceride-rich particles.
Factors that influence your panel results
Your results can shift based on recent diet changes, weight loss or gain, alcohol intake, acute illness, and how long you fasted (triglycerides are especially sensitive). Medications can strongly influence the pattern: statins typically lower LDL-C and ApoB, ezetimibe can further reduce LDL-related markers, and PCSK9-targeting therapies can substantially lower LDL-related measures and may modestly affect Lp(a) depending on the therapy. Thyroid function, kidney disease, pregnancy, and uncontrolled diabetes can also change lipid patterns. Lp(a) is different: it is largely genetic and usually stable, so a single measurement is often enough to establish whether it is a meaningful inherited risk factor, while the rest of the panel is more useful to trend after lifestyle or medication changes.
What’s included in this panel
- Lipoprotein (A)
- Cholesterol, Total
- Hdl Cholesterol
- Triglycerides
- Ldl-Cholesterol
- Chol/Hdlc Ratio
- Ldl/Hdl Ratio
- Non Hdl Cholesterol
Frequently Asked Questions
Do I need to fast for this panel?
Fasting is often recommended because triglycerides and some derived lipid calculations can shift after eating. If you cannot fast, you can still get useful information, but interpret triglycerides and any triglyceride-driven calculations with extra caution.
How is this different from a standard lipid panel?
A standard lipid panel focuses on total cholesterol, LDL-C, HDL-C, and triglycerides. This panel adds higher-resolution risk markers—especially Lp(a) and ApoB/particle-related measures—so you can see whether your atherogenic particle burden is truly controlled and whether inherited Lp(a) risk is present.
If my LDL cholesterol is “normal,” can I still have higher risk on this panel?
Yes. Some people have LDL-C that looks acceptable while ApoB or LDL particle number remains high (often called discordance). That pattern can occur with insulin resistance, high triglycerides, or certain genetic profiles, and it can change what you and your clinician focus on.
How often should I repeat the High-Risk Heart Health Lipid and Lp(a) Panel?
Lp(a) is usually stable and often does not need frequent repeats. The rest of the panel is commonly repeated after a meaningful change—such as starting or adjusting lipid-lowering medication, significant weight change, or a sustained diet change. Your clinician may suggest an interval like 6–12 weeks after a medication change for lipids, then less often once stable.
What should I do if my Lp(a) is high?
A high Lp(a) is often inherited and not strongly lowered by lifestyle alone, so the usual strategy is to control the modifiable parts of risk more tightly—especially ApoB-containing particles, blood pressure, glucose/insulin resistance, and smoking status. You may also discuss imaging (like coronary calcium scoring) or therapy intensity with your clinician based on your overall risk profile.
Is ApoB more important than LDL-C?
They are related, but they are not identical. LDL-C reflects the cholesterol carried inside particles, while ApoB reflects the number of atherogenic particles. In many higher-risk situations—especially when triglycerides are elevated or insulin resistance is present—ApoB can be a more direct marker to follow alongside LDL-C and non-HDL.
Is it better to order this panel or order tests one by one?
A bundled panel is often simpler because it captures the key markers that help you interpret each other. Ordering one-by-one can lead to gaps (for example, getting LDL-C without ApoB or Lp(a)), which makes it harder to understand why your numbers look the way they do and what to prioritize.